Alzheimer's disease is a kind of mental disorder called "dementia" that affects the brain's normal activities like thinking and memorizing. Alzheimer patients have to undergo through variety of laboratory tests, medical assessments. There is no single test available for this disease.
A new test has been conducted on rat to check the power of a drug.
IRL-1620 is a new drug that has been tested on rats to treat complete Alzheimer disease. At present, there are 5 treatment available for treating only symptoms of Alzheimer and not the complete disease.
After testing this drug on rats, it was found that this drug is helpful in improving memory, enhance working of brain response and reduce stress in rats infected with Alzheimer.
Seema Briyal, a senior scientists at Midwestern University in Downers Grove, IL report that "We used the novel approach of stimulating the Endothelin B receptors by intravenous injection of IRL-1620 to prevent and repair the damage to the brain caused by Alzheimer's disease,".
Endothelin B (ETB) receptors is already identified to be important in brain development and provide protection to nervous system.
Resource: http://www.medicalnewstoday.com/articles/299045.php
Post a Comment